Inhibition of alpha-glucosidase reduces carbohydrate digestion, consequently decreasing carbohydrate content in blood, which improves human health outcomes regarding type 2 diabetes [31,53]. This evidence concerns the gene GAA and type 2 diabetes mellitus.